- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02166164
Characterization of Secondary Hyperalgesia in Healthy Volunteers
In this prospective trial we aim to investigate the intra-individual and inter-individual variance in secondary hyperalgesia following pain elicited by the experimental pain model: Brief Thermal Sensitization.
Furthermore we wish to investigate how precise the psychological tests, Pain Catastrophizing Scale and Hospital Anxiety and Depression Scale predict the size of the area of secondary hyperalgesia.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Copenhagen, Denmark, 2100
- Department of anaesthesia and surgery, 4231, Rigshospitalet
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age >18 years and <35 years
- Speak and understand Danish
- Male gender
- Test subjects who have understood and signed the informed consent
- No prescription medicine during the last 30 days
Exclusion Criteria:
- Test subjects that cannot cooperate to the test
- Test subjects with an alcohol and/or substance abuse, assessed by the investigator
- Test subjects, who have consumed one or several types of analgesics 2 <days before the study
- Test subjects, who have consumed antidepressant medication during the last 30 days before the study
- Test subjects with chronic pain
- Test subjects with psychiatric diagnoses
- Test subjects with tattoos on the extremities
- Body Mass Index of >30 or <18
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experiemental pain models
all study participants will be tested with the same experimental pain models: Brief thermal sensitization, Long thermal stimulation, and Heat-pain-detection threshold.
|
A small area of the skin of the study participants are heated to 45 degree celsius for 3 minutes, followed by evaluation of secondary hyperalgesia.
Other Names:
A small area of the skin of the study participants are heated to 45 degrees celsius for 1 minute.
During the 1 minute period, the study participant will continually report pain on an electronic visual analog scale.
Other Names:
The threshold for heat pain are evaluated by heating a small area of the study participants skin. When the study participant feels pain, the temperature (degrees celsius) is registered. 4 threshold measurements per session. Heat pain threshold is defined as the average temperature of the 4 measurements.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in area of secondary hyperalgesia following brief thermal sensitization
Time Frame: Study day 1, 2, 3, and 4. A minimum of 4 weeks.
|
To determine the intra- and inter-individual variance, and the inter- and intra-observer variance of the secondary hyperalgesia areas following brief thermal sensitization on 4 separate experimental days with two different observers.
|
Study day 1, 2, 3, and 4. A minimum of 4 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Score of Pain Catastrophizing Scale
Time Frame: 7 days
|
How precise does the score of the Pain Catastrophizing Scale predict the size of the area of secondary hyperalgesia?
|
7 days
|
Score of Hospital Anxiety and Depression Scale
Time Frame: 7 days
|
How precise does the score of the Hospital Anxiety and Depression Scale predict the size of the area of secondary hyperalgesia?
|
7 days
|
Score of Subscales of Pain Catastrophizing Scale and Hospital Anxiety and Depression Scale
Time Frame: 7 days
|
How precise do the subscales in the two psychological tests (PCS-rumination, PCS-magnification, PCS-helplessness, and HADS-Anxiety, HADS-Depression) predict the size of the area of secondary hyperalgesia?
|
7 days
|
Heat-pain-detection threshold registered by degrees celsius
Time Frame: 1 minute per session
|
How precise do the Heat-pain-detection threshold evaluated on the 4 experimental days predict the size of the area of secondary hyperalgesia on the respective 4 experimental days? 4 sessions of Heat-pain-detection threshold on 4 separate experimental days with 1 session per experimental day.
|
1 minute per session
|
Pain following Long Thermal Stimulation, evaluated by maximum on the visual analog scale
Time Frame: 1 minute per session
|
How precise does the Max.
VAS-score following Long Thermal Stimulation evaluated on the 4 experimental days predict the size of the area of secondary hyperalgesia on the respective 4 experimental days? 4 sessions of Long Thermal Stimulation on 4 separate experimental days with 1 session per experimental day.
|
1 minute per session
|
Pain following Long Thermal Stimulation, evaluated by Area under the curve of the visual analog scale.
Time Frame: 1 minute per session
|
How precise does the VAS-Area Under the Curve following Long Thermal Stimulation evaluated on the 4 experimental days predict the size of the area of secondary hyperalgesia on the respective 4 experimental days? 4 sessions of Long Thermal Stimulation on 4 separate experimental days with 1 session per study day.
|
1 minute per session
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Jørgen B Dahl, MD, Doc. Med, Consultant, Department of anaesthesiology, dep. Z, Bispebjerg Hospital, Denmark
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SM1-MSH-2014
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Experimental Pain in Healthy Males
-
Technical University of MunichGerman Research FoundationCompleted
-
Technical University of MunichGerman Research FoundationCompletedExperimental Pain in Healthy Human SubjectsGermany
-
Technical University of MunichGerman Research Foundation; Studienstiftung des deutschen VolkesRecruitingExperimental Pain in Healthy Human SubjectsGermany
-
Technical University of MunichGerman Research FoundationCompletedExperimental Pain in Healthy Human ParticipantsGermany
-
Sunnybrook Health Sciences CentreOntario Institute for Cancer ResearchCompleted
-
Bispebjerg HospitalUniversity of CopenhagenUnknownErgogenic Effects of Salbutamol in Healthy MalesDenmark
-
University of PernambucoCompleted
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedHealthy MalesUnited States
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
Clinical Trials on Brief thermal sensitization
-
Rigshospitalet, DenmarkUniversity of Copenhagen; Copenhagen Trial Unit, Center for Clinical Intervention...Completed
-
Hospices Civils de LyonUnknown
-
SangathHarvard Medical School (HMS and HSDM); London School of Hygiene and Tropical...Completed
-
University of MonastirCompletedComplementary InvestigationsTunisia
-
Mahidol UniversityCompletedImmediate Type Hypersensitivity
-
London School of Hygiene and Tropical MedicineCompleted
-
Benno Rehberg-KlugCompleted
-
Université Catholique de LouvainRecruitingSleep Quality | Gut Microbiota | Sensitization, Central | Peripheral SensitizationBelgium
-
University of ChicagoNational Cancer Institute (NCI)WithdrawnStage IA Breast Cancer | Stage IB Breast Cancer | Ductal Breast Carcinoma in Situ | Invasive Ductal Breast CarcinomaUnited States